Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergy
[...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was signific...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 142; no. 1; pp. 335 - 338.e9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.07.2018
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was significantly lower among subjects born by Cesarean section than among subjects born by vaginal delivery (P = .049). Asthma or recurrent wheeze was based on parental report of physician diagnosis of asthma or recurrent wheeze in the first 3 years of life as previously reported.4 Questionnaire responses were used to determine whether a child was ingesting breast milk and/or formula, and whether solid foods had been introduced at the time of stool sample collection as previously described.E1Fecal sample collection and profiling Stool collection and microbiome profiling methods have been described in detail previously.E2 DNA extraction was performed on the stool samples and sequencing of the bacterial 16S V3 to V5 hypervariable regions was performed by pyrosequencing (Roche 454 Titanium platform) at the Genome Center (TGI) at Washington University in St Louis, Mo. Subject Food Reaction∗ Age (mo) reported Diagnosis method Serum specific IgE (kU/L) Walnut Peanut Egg white Milk Wheat Soybean 1 Sesame seed Unknown 24 Blood and skin test <0.10 1.00 5.42 0.67 0.42 0.63 Egg Unknown 24 Other nut Unknown 24 Peanut Rash 24 2 Soy Diarrhea, nausea, hives 12 Blood and skin test <0.10 2.05 22.4 1.9 0.65 1.27 Wheat Diarrhea, nausea, hives 12 Peanut Diarrhea, nausea, hives 12 Egg Diarrhea, nausea, hives 12 Other nut Unknown 15 Fish Diarrhea, nausea, hives 24 3 Milk Hives, nausea, wheeze, worsened eczema 12 Blood test and skin test 3.05 8.72 5.03 9.88 5.06 3.89 Egg Nausea, vomiting, wheeze, sneezing/runny nose, watery eyes, hives, worsened eczema, fatigue 12 Peanut Nausea 12 Other fish Hives, nausea, diarrhea, worsened eczema, facial swelling, fussiness 12 Soy Hives, fussiness, vaginal itching, nausea, diarrhea 18 Shellfish Facial swelling, hives, worsened eczema, fussiness, nausea, diarrhea 18 Wheat Hives, fussiness, vaginal itching, nausea 21 4 Shellfish Hives, worsened eczema, nausea 12 Blood test and skin test 5.03 1.33 0.53 <0.10 0.38 0.28 Other fish Hives, worsened eczema, nausea 12 Egg Hives, wheeze, worsened eczema, nausea 12 Hot dog Hives 15 Milk Hives, worsened eczema, nausea 24 Wheat Hives 24 Peanut Hives, worsened eczema, nausea 27 5 Egg Nausea, hives, fatigue 18 Skin test 0.66 1.32 1.59 4.24 0.78 2.28 6 Peanut Hives, wheezing, sneezing, red eyes 24 History 12.7 >100 38.5 26 29 96.3 7 Other nut Eyes swelled shut, itchy 36 Skin test 0.72 2.07 4.41 8.51 1.95 0.96 8 Unknown Unknown 15 Blood test 0.25 >100 0.71 <0.10 0.15 2.2 Peanut Hives 24 9 Peanut Hives on 1 body part only 15 Blood and skin test 1.54 9.76 5.67 0.94 2.07 2.96 Egg Nausea, hives 15 Pea Hives on 1 body part only 24 Lentil Hives on 1 body part only 24 Other nut Unknown 30 10 Peanut Not asked† 12 Not asked† <0.10 0.79 0.43 0.25 0.27 <0.10 Egg Not asked† 12 11 Egg Not asked† 12 Not asked† <0.10 <0.10 0.62 <0.10 <0.10 <0.10 12 Egg Hives on 1 body part only, nausea, cough 27 Blood test <0.10 0.37 3.75 1.88 0.90 0.91 Candy/sweets Nausea 36 Table E1 Clinical history and serum specific IgE for food-allergic subjects Characteristic All children (n = 81) All subjects (n = 83) Subjects with iNKT-cell activity data (n = 57) Food allergic (n = 12) Food sensitive (n = 32) Control (n = 37) P value Food allergic (n = 8) Food sensitive (n = 22) Control (n = 27) P value Sex, n (%) .66 .17 Male 41 (51) 5 (42) 18 (56) 18 (49) 2 (25) 14 (64) 13 (48) Female 40 (49) 7 (58) 14 (44) 19 (51) 6 (75) 8 (36) 14 (52) Race/ethnicity, n (%) .94 .98 Black, non-Hispanic 34 (42) 6 (50) 13 (41) 15 (41) 4 (50) 9 (41) 10 (37) White, non-Hispanic 26 (32) 4 (33) 11 (34) 11 (30) 2 (25) 6 (27) 9 (33) Hispanic 21 (26) 2 (17) 8 (25) 11 (30) 2 (25) 7 (32) 8 (30) Birth by Cesarean section, n (%) 24 (30) 6 (50) 5 (16) 13 (35) .052 5 (63) 2 (9) 9 (33) .01 Gestational age (wk), mean ± SD 39.1 ± 1.6 39.4 ± 1.7 38.9 ± 1.9 39.4 ± 1.4 .48 39.3 ± 1.6 38.8 ± 2.2 39.4 ± 1.4 .79 Number of living children born to mother, mean ± SD 0.9 ± 0.9 1.2 ± 0.9 1.0 ± 0.9 0.8 ± 0.9 .40 1.3 ± 0.9 0.8 ± 0.8 0.8 ± 0.9 .36 Antibiotic exposure, n (%) Perinatal antibiotics 35 (43) 8 (67) 11 (34) 16 (43) .16 5 (63) 8 (36) 11 (41) .44 By age 6 mo 15 (19) 2 (17) 5 (16) 8 (22) .86 1 (13) 3 (14) 7 (26) .59 By age 3 y 69 (85) 11 (92) 29 (91) 29 (78) .36 7 (87) 21 (95) 20 (74) .10 Pet dog in home, n (%) In first 6 mo of life 22 (28) 3 (33) 6 (19) 13 (36) .31 2 (25) 3 (14) 10 (37) .19 Between age 6 and 36 mo 32 (41) 3 (33) 13 (43) 16 (43) .52 2 (25) 10 (50) 11 (41) .53 Pet cat in home, n (%) In first 6 mo of life 11 (14) 2 (17) 4 (13) 5 (14) .91 1 (13) 2 (9) 4 (15) .86 Between age 6 and 36 mo 20 (25) 6 (50) 5 (17) 9 (24) .10 3 (38) 2 (10) 6 (22) .22 Daycare by age 3 y, n (%) 43 (53) 7 (58) 15 (47) 21 (57) .72 4 (50) 10 (45) 14 (52) .93 Age at stool sample collection (mo), mean ± SD 4.6 ± 1.1 5.0 ± 1.0 5.0 ± 1.0 4.1 ± 1.0 <.01 5.0 ± 1.0 5.1 ± 1.0 4.2 ± 1.1 .02 Diet at stool sample collection, n (%) Breast-feeding 34 (42) 6 (50) 13 (41) 15 (41) .91 4 (50) 7 (32) 12 (44) .57 Formula 50 (62) 7 (58) 20 (63) 23 (62) 1 4 (50) 16 (73) 17 (63) .51 Solid foods 33 (41) 6 (50) 19 (61) 8 (22) <.01 4 (50) 12 (57) 7 (26) .07 Asthma/recurrent wheeze by age 3 y, n (%) 25 (31) 8 (67) 9 (28) 8 (22) .02 6 (75) 7 (32) 4 (15) <.01 VDAART treatment group, n (%) 1 1 4400 IU/d vitamin D 41 (51) 6 (50) 16 (50) 19 (51) 4 (50) 11 (50) 13 (48) 400 IU/d vitamin D 40 (49) 6 (50) 16 (50) 18 (49) 4 (50) 11 (50) 14 (52) Study center, n (%) .27 .71 Boston 23 (28) 4 (33) 8 (25) 11 (30) 1 (13) 2 (9) 7 (26) St Louis 42 (52) 7 (58) 20 (63) 15 (41) 3 (38) 7 (32) 9 (33) San Diego 16 (20) 1 (8) 4 (13) 11 (30) 4 (50) 13 (59) 11 (41) Maternal education, n (%) .92 .74 Less than high school 10 (12) 1 (8) 3 (9) 6 (16) 0 (0) 3 (14) 4 (15) High school or technical school 26 (32) 5 (42) 11 (34) 10 (27) 4 (50) 8 (36) 6 (22) Some college 10 (12) 2 (17) 4 (13) 4 (11) 1 (13) 3 (14) 3 (11) College graduate or graduate school 35 (43) 4 (33) 14 (44) 17 (46) 3 (38) 8 (36) 14 (52) Household income (US $), n (%) .57 .55 <30,000 29 (36) 6 (50) 12 (38) 11 (30) 5 (63) 8 (36) 8 (30) 30,000-49,999 11 (14) 1 (8) 5 (16) 5 (14) 0 (0) 4 (18) 4 (15) 50,000-74,999 9 (11) 1 (8) 3 (9) 5 (14) 1 (13) 3 (14) 4 (15) 75,000-99,999 8 (10) 1 (8) 1 (3) 6 (16) 1 (13) 0 (0) 4 (15) 100,000-149,999 10 (12) 2 (17) 2 (6) 6 (16) 1 (13) 1 (5) 4 (15) At least 150,000 5 (6) 0 (0) 4 (13) 1 (3) 0 (0) 2 (9) 1 (4) Refused to say or unknown 9 (11) 1 (8) 5 (16) 3 (8) 0 (0) 4 (18) 2 (7) Table E2 Baseline characteristics of children and upstream predictors of the intestinal microenvironment Food-allergic (n = 12) vs control (n = 37, reference) Food-sensitive (n = 32) vs control (n = 37, reference) Food-allergic (n = 12) vs food-sensitive (n = 32, reference) Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value 7-Methylguanine 0.29 (0.11-0.63) .004 3-Ketosphinganine 2.49 (1.37-4.89) .004 3-Hydroxypalmitate 0.23 (0.07-0.59) .01 Docosapentaenoate (n3 DPA; 22:5n3) 0.24 (0.07-0.64) .01 Pimelate (heptanedioate) 2.83 (1.38-6.29) .01 Ribonate 0.32 (0.13-0.69) .01 2-Aminophenol 3.20 (1.40-8.68) .01 Pyridoxine (vitamin B6) 3.08 (1.40-7.63) .01 1-Palmitoyl-GPI (16:0) 0.25 (0.08-0.63) .01 Bilirubin (E,Z or Z,E)∗ 0.20 (0.05-0.62) .01 Cis-urocanate 0.24 (0.07-0.66) .01 1-Palmitoyl-GPS (16:0)∗ 0.25 (0.08-0.65) .01 Histidine 0.11 (0.01-0.53) .01 Diacetylchitobiose 0.38 (0.16, -0.79) .01 I-urobilinogen 0.42 (0.20-0.79) .01 N-formylmethionine 0.28 (0.09-0.72) .01 N-acetylglutamate 0.25 (0.07-0.73) .02 Sphinganine 0.15 (0.03-0.56) .01 I-urobilinogen 0.43 (0.20-0.82) .02 5alpha-pregnan-3beta,20alpha-diol monosulfate (1) 3.04 (1.31-8.77) .02 2-Methylserine 0.32 (0.11-0.75) .02 Dihomo-linolenate (20:3n3 or n6) 0.25 (0.06-0.66) .02 N-carbamoylaspartate 0.38 (0.15-0.81) .02 13-Methylmyristate 0.39 (0.17-0.82) .02 Serine 0.11 (0.01-0.59) .02 N-acetylasparagine 0.26 (0.08-0.78) .02 Dihomo-linolenate (20:3n3 or n6) 0.24 (0.06-0.67) .02 2-Methylserine 0.20 (0.04-0.68) .03 Lysylleucine 2.23 (1.15-4.69) .02 Glycylisoleucine 0.25 (0.07-0.70) .02 5,6-Dihydrothymine 0.40 (0.16-0.86) .03 Vanillic alcohol sulfate 0.42 (0.18-0.86) .03 D-urobilin 0.40 (0.17-0.83) .02 3-Hydroxypalmitate 0.27 (0.07-0.79) .03 Docosahexenoylcarnitine (C22:6)∗ 0.37 (0.14-0.83) .03 Docosapentaenoate (n3 DPA; 22:5n3) 0.26 (0.07-0.74) .02 Phenethylamine 0.32 (0.10-0.83) .03 Ursodeoxycholate sulfate (1) 0.57 (0.34-0.92) .03 7-Methylguanine 0.47 (0.23-0.90) .03 D-urobilin 0.42 (0.18-0.91) .04 3-Methylglutarate/2-methylglutarate 2.35 (1.14-5.35) .03 Sucrose 0.37 (0.14-0.85) .03 Ursodeoxycholate sulfate (1) 0.45 (0.20-0.90) .04 N-palmitoylserine 1.87 (1.08-3.36) .03 1-Palmitoyl-GPE (16:0) 0.20 (0.04-0.73) .03 Tryptamine 0.44 (0.19-0.90) .04 Malonylcarnitine 0.39 (0.16-0.87) .03 21-Hydroxypregnenolone disulfate 0.31 (0.09-0.80) .03 2,3-Dimethylsuccinate 3.06 (1.09-9.72) .04 13-Methylmyristate 1.97 (1.08-3.80) .03 N-acetylglycine 3.33 (1.21-11.18) .03 Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] 2.56 (1.09-6.94) .04 Dopamine 3-O-sulfate 0.45 (0.21-0.90) .03 Alpha-CEHC 0.32 (0.10-0.840) .03 Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1]∗ 2.56 (1.08-7.07) .04 Glutaminylleucine 2.58 (1.12-6.57) .03 Glycerophosphoserine∗ 0.28 (0.08-0.82) .03 Tyrosine 0.16 (0.02-0.86) .04 N2,N6-diacetyllysine 0.41 (0.17-0.90) .03 Bilirubin (E,Z or Z,E)∗ 0.32 (0.10-0.87) .04 Formiminoglutamate 0.36 (0.11-0.90) .04 N-acetyl-aspartyl-glutamate (NAAG) 0.41 (0.17-0.91) .04 Glycylvaline 0.24 (0.05-0.87) .04 Linolenate (alpha or gamma; [18:3n3 or 6]) 0.27 (0.06-0.86) .04 N-alpha-acetylornithine 0.39 (0.15-0.91) .04 Linoleoyl ethanolamide 0.42 (0.17-0.94) .04 Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2]∗ 2.39 (1.04-6.06) .05 Allo-threonine 0.40 (0.15-0.90) .04 3-Ureidoisobutyrate 0.45 ( |
---|---|
AbstractList | [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations between mode of delivery and phenotype-associated microbiome and metabolome perturbations. [...]fecal lipid iNKT-cell activation was significantly lower among subjects born by Cesarean section than among subjects born by vaginal delivery (P = .049). Asthma or recurrent wheeze was based on parental report of physician diagnosis of asthma or recurrent wheeze in the first 3 years of life as previously reported.4 Questionnaire responses were used to determine whether a child was ingesting breast milk and/or formula, and whether solid foods had been introduced at the time of stool sample collection as previously described.E1Fecal sample collection and profiling Stool collection and microbiome profiling methods have been described in detail previously.E2 DNA extraction was performed on the stool samples and sequencing of the bacterial 16S V3 to V5 hypervariable regions was performed by pyrosequencing (Roche 454 Titanium platform) at the Genome Center (TGI) at Washington University in St Louis, Mo. Subject Food Reaction∗ Age (mo) reported Diagnosis method Serum specific IgE (kU/L) Walnut Peanut Egg white Milk Wheat Soybean 1 Sesame seed Unknown 24 Blood and skin test <0.10 1.00 5.42 0.67 0.42 0.63 Egg Unknown 24 Other nut Unknown 24 Peanut Rash 24 2 Soy Diarrhea, nausea, hives 12 Blood and skin test <0.10 2.05 22.4 1.9 0.65 1.27 Wheat Diarrhea, nausea, hives 12 Peanut Diarrhea, nausea, hives 12 Egg Diarrhea, nausea, hives 12 Other nut Unknown 15 Fish Diarrhea, nausea, hives 24 3 Milk Hives, nausea, wheeze, worsened eczema 12 Blood test and skin test 3.05 8.72 5.03 9.88 5.06 3.89 Egg Nausea, vomiting, wheeze, sneezing/runny nose, watery eyes, hives, worsened eczema, fatigue 12 Peanut Nausea 12 Other fish Hives, nausea, diarrhea, worsened eczema, facial swelling, fussiness 12 Soy Hives, fussiness, vaginal itching, nausea, diarrhea 18 Shellfish Facial swelling, hives, worsened eczema, fussiness, nausea, diarrhea 18 Wheat Hives, fussiness, vaginal itching, nausea 21 4 Shellfish Hives, worsened eczema, nausea 12 Blood test and skin test 5.03 1.33 0.53 <0.10 0.38 0.28 Other fish Hives, worsened eczema, nausea 12 Egg Hives, wheeze, worsened eczema, nausea 12 Hot dog Hives 15 Milk Hives, worsened eczema, nausea 24 Wheat Hives 24 Peanut Hives, worsened eczema, nausea 27 5 Egg Nausea, hives, fatigue 18 Skin test 0.66 1.32 1.59 4.24 0.78 2.28 6 Peanut Hives, wheezing, sneezing, red eyes 24 History 12.7 >100 38.5 26 29 96.3 7 Other nut Eyes swelled shut, itchy 36 Skin test 0.72 2.07 4.41 8.51 1.95 0.96 8 Unknown Unknown 15 Blood test 0.25 >100 0.71 <0.10 0.15 2.2 Peanut Hives 24 9 Peanut Hives on 1 body part only 15 Blood and skin test 1.54 9.76 5.67 0.94 2.07 2.96 Egg Nausea, hives 15 Pea Hives on 1 body part only 24 Lentil Hives on 1 body part only 24 Other nut Unknown 30 10 Peanut Not asked† 12 Not asked† <0.10 0.79 0.43 0.25 0.27 <0.10 Egg Not asked† 12 11 Egg Not asked† 12 Not asked† <0.10 <0.10 0.62 <0.10 <0.10 <0.10 12 Egg Hives on 1 body part only, nausea, cough 27 Blood test <0.10 0.37 3.75 1.88 0.90 0.91 Candy/sweets Nausea 36 Table E1 Clinical history and serum specific IgE for food-allergic subjects Characteristic All children (n = 81) All subjects (n = 83) Subjects with iNKT-cell activity data (n = 57) Food allergic (n = 12) Food sensitive (n = 32) Control (n = 37) P value Food allergic (n = 8) Food sensitive (n = 22) Control (n = 27) P value Sex, n (%) .66 .17 Male 41 (51) 5 (42) 18 (56) 18 (49) 2 (25) 14 (64) 13 (48) Female 40 (49) 7 (58) 14 (44) 19 (51) 6 (75) 8 (36) 14 (52) Race/ethnicity, n (%) .94 .98 Black, non-Hispanic 34 (42) 6 (50) 13 (41) 15 (41) 4 (50) 9 (41) 10 (37) White, non-Hispanic 26 (32) 4 (33) 11 (34) 11 (30) 2 (25) 6 (27) 9 (33) Hispanic 21 (26) 2 (17) 8 (25) 11 (30) 2 (25) 7 (32) 8 (30) Birth by Cesarean section, n (%) 24 (30) 6 (50) 5 (16) 13 (35) .052 5 (63) 2 (9) 9 (33) .01 Gestational age (wk), mean ± SD 39.1 ± 1.6 39.4 ± 1.7 38.9 ± 1.9 39.4 ± 1.4 .48 39.3 ± 1.6 38.8 ± 2.2 39.4 ± 1.4 .79 Number of living children born to mother, mean ± SD 0.9 ± 0.9 1.2 ± 0.9 1.0 ± 0.9 0.8 ± 0.9 .40 1.3 ± 0.9 0.8 ± 0.8 0.8 ± 0.9 .36 Antibiotic exposure, n (%) Perinatal antibiotics 35 (43) 8 (67) 11 (34) 16 (43) .16 5 (63) 8 (36) 11 (41) .44 By age 6 mo 15 (19) 2 (17) 5 (16) 8 (22) .86 1 (13) 3 (14) 7 (26) .59 By age 3 y 69 (85) 11 (92) 29 (91) 29 (78) .36 7 (87) 21 (95) 20 (74) .10 Pet dog in home, n (%) In first 6 mo of life 22 (28) 3 (33) 6 (19) 13 (36) .31 2 (25) 3 (14) 10 (37) .19 Between age 6 and 36 mo 32 (41) 3 (33) 13 (43) 16 (43) .52 2 (25) 10 (50) 11 (41) .53 Pet cat in home, n (%) In first 6 mo of life 11 (14) 2 (17) 4 (13) 5 (14) .91 1 (13) 2 (9) 4 (15) .86 Between age 6 and 36 mo 20 (25) 6 (50) 5 (17) 9 (24) .10 3 (38) 2 (10) 6 (22) .22 Daycare by age 3 y, n (%) 43 (53) 7 (58) 15 (47) 21 (57) .72 4 (50) 10 (45) 14 (52) .93 Age at stool sample collection (mo), mean ± SD 4.6 ± 1.1 5.0 ± 1.0 5.0 ± 1.0 4.1 ± 1.0 <.01 5.0 ± 1.0 5.1 ± 1.0 4.2 ± 1.1 .02 Diet at stool sample collection, n (%) Breast-feeding 34 (42) 6 (50) 13 (41) 15 (41) .91 4 (50) 7 (32) 12 (44) .57 Formula 50 (62) 7 (58) 20 (63) 23 (62) 1 4 (50) 16 (73) 17 (63) .51 Solid foods 33 (41) 6 (50) 19 (61) 8 (22) <.01 4 (50) 12 (57) 7 (26) .07 Asthma/recurrent wheeze by age 3 y, n (%) 25 (31) 8 (67) 9 (28) 8 (22) .02 6 (75) 7 (32) 4 (15) <.01 VDAART treatment group, n (%) 1 1 4400 IU/d vitamin D 41 (51) 6 (50) 16 (50) 19 (51) 4 (50) 11 (50) 13 (48) 400 IU/d vitamin D 40 (49) 6 (50) 16 (50) 18 (49) 4 (50) 11 (50) 14 (52) Study center, n (%) .27 .71 Boston 23 (28) 4 (33) 8 (25) 11 (30) 1 (13) 2 (9) 7 (26) St Louis 42 (52) 7 (58) 20 (63) 15 (41) 3 (38) 7 (32) 9 (33) San Diego 16 (20) 1 (8) 4 (13) 11 (30) 4 (50) 13 (59) 11 (41) Maternal education, n (%) .92 .74 Less than high school 10 (12) 1 (8) 3 (9) 6 (16) 0 (0) 3 (14) 4 (15) High school or technical school 26 (32) 5 (42) 11 (34) 10 (27) 4 (50) 8 (36) 6 (22) Some college 10 (12) 2 (17) 4 (13) 4 (11) 1 (13) 3 (14) 3 (11) College graduate or graduate school 35 (43) 4 (33) 14 (44) 17 (46) 3 (38) 8 (36) 14 (52) Household income (US $), n (%) .57 .55 <30,000 29 (36) 6 (50) 12 (38) 11 (30) 5 (63) 8 (36) 8 (30) 30,000-49,999 11 (14) 1 (8) 5 (16) 5 (14) 0 (0) 4 (18) 4 (15) 50,000-74,999 9 (11) 1 (8) 3 (9) 5 (14) 1 (13) 3 (14) 4 (15) 75,000-99,999 8 (10) 1 (8) 1 (3) 6 (16) 1 (13) 0 (0) 4 (15) 100,000-149,999 10 (12) 2 (17) 2 (6) 6 (16) 1 (13) 1 (5) 4 (15) At least 150,000 5 (6) 0 (0) 4 (13) 1 (3) 0 (0) 2 (9) 1 (4) Refused to say or unknown 9 (11) 1 (8) 5 (16) 3 (8) 0 (0) 4 (18) 2 (7) Table E2 Baseline characteristics of children and upstream predictors of the intestinal microenvironment Food-allergic (n = 12) vs control (n = 37, reference) Food-sensitive (n = 32) vs control (n = 37, reference) Food-allergic (n = 12) vs food-sensitive (n = 32, reference) Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value Metabolite Odds ratio (95% CI) P value 7-Methylguanine 0.29 (0.11-0.63) .004 3-Ketosphinganine 2.49 (1.37-4.89) .004 3-Hydroxypalmitate 0.23 (0.07-0.59) .01 Docosapentaenoate (n3 DPA; 22:5n3) 0.24 (0.07-0.64) .01 Pimelate (heptanedioate) 2.83 (1.38-6.29) .01 Ribonate 0.32 (0.13-0.69) .01 2-Aminophenol 3.20 (1.40-8.68) .01 Pyridoxine (vitamin B6) 3.08 (1.40-7.63) .01 1-Palmitoyl-GPI (16:0) 0.25 (0.08-0.63) .01 Bilirubin (E,Z or Z,E)∗ 0.20 (0.05-0.62) .01 Cis-urocanate 0.24 (0.07-0.66) .01 1-Palmitoyl-GPS (16:0)∗ 0.25 (0.08-0.65) .01 Histidine 0.11 (0.01-0.53) .01 Diacetylchitobiose 0.38 (0.16, -0.79) .01 I-urobilinogen 0.42 (0.20-0.79) .01 N-formylmethionine 0.28 (0.09-0.72) .01 N-acetylglutamate 0.25 (0.07-0.73) .02 Sphinganine 0.15 (0.03-0.56) .01 I-urobilinogen 0.43 (0.20-0.82) .02 5alpha-pregnan-3beta,20alpha-diol monosulfate (1) 3.04 (1.31-8.77) .02 2-Methylserine 0.32 (0.11-0.75) .02 Dihomo-linolenate (20:3n3 or n6) 0.25 (0.06-0.66) .02 N-carbamoylaspartate 0.38 (0.15-0.81) .02 13-Methylmyristate 0.39 (0.17-0.82) .02 Serine 0.11 (0.01-0.59) .02 N-acetylasparagine 0.26 (0.08-0.78) .02 Dihomo-linolenate (20:3n3 or n6) 0.24 (0.06-0.67) .02 2-Methylserine 0.20 (0.04-0.68) .03 Lysylleucine 2.23 (1.15-4.69) .02 Glycylisoleucine 0.25 (0.07-0.70) .02 5,6-Dihydrothymine 0.40 (0.16-0.86) .03 Vanillic alcohol sulfate 0.42 (0.18-0.86) .03 D-urobilin 0.40 (0.17-0.83) .02 3-Hydroxypalmitate 0.27 (0.07-0.79) .03 Docosahexenoylcarnitine (C22:6)∗ 0.37 (0.14-0.83) .03 Docosapentaenoate (n3 DPA; 22:5n3) 0.26 (0.07-0.74) .02 Phenethylamine 0.32 (0.10-0.83) .03 Ursodeoxycholate sulfate (1) 0.57 (0.34-0.92) .03 7-Methylguanine 0.47 (0.23-0.90) .03 D-urobilin 0.42 (0.18-0.91) .04 3-Methylglutarate/2-methylglutarate 2.35 (1.14-5.35) .03 Sucrose 0.37 (0.14-0.85) .03 Ursodeoxycholate sulfate (1) 0.45 (0.20-0.90) .04 N-palmitoylserine 1.87 (1.08-3.36) .03 1-Palmitoyl-GPE (16:0) 0.20 (0.04-0.73) .03 Tryptamine 0.44 (0.19-0.90) .04 Malonylcarnitine 0.39 (0.16-0.87) .03 21-Hydroxypregnenolone disulfate 0.31 (0.09-0.80) .03 2,3-Dimethylsuccinate 3.06 (1.09-9.72) .04 13-Methylmyristate 1.97 (1.08-3.80) .03 N-acetylglycine 3.33 (1.21-11.18) .03 Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] 2.56 (1.09-6.94) .04 Dopamine 3-O-sulfate 0.45 (0.21-0.90) .03 Alpha-CEHC 0.32 (0.10-0.840) .03 Palmitoyl-linoleoyl-glycerol (16:0/18:2) [1]∗ 2.56 (1.08-7.07) .04 Glutaminylleucine 2.58 (1.12-6.57) .03 Glycerophosphoserine∗ 0.28 (0.08-0.82) .03 Tyrosine 0.16 (0.02-0.86) .04 N2,N6-diacetyllysine 0.41 (0.17-0.90) .03 Bilirubin (E,Z or Z,E)∗ 0.32 (0.10-0.87) .04 Formiminoglutamate 0.36 (0.11-0.90) .04 N-acetyl-aspartyl-glutamate (NAAG) 0.41 (0.17-0.91) .04 Glycylvaline 0.24 (0.05-0.87) .04 Linolenate (alpha or gamma; [18:3n3 or 6]) 0.27 (0.06-0.86) .04 N-alpha-acetylornithine 0.39 (0.15-0.91) .04 Linoleoyl ethanolamide 0.42 (0.17-0.94) .04 Linoleoyl-linolenoyl-glycerol (18:2/18:3) [2]∗ 2.39 (1.04-6.06) .05 Allo-threonine 0.40 (0.15-0.90) .04 3-Ureidoisobutyrate 0.45 ( |
Author | Zeiger, Robert S. Beigelman, Avraham Laranjo, Nancy O'Connor, George T. Lee-Sarwar, Kathleen Brennan, Patrick J. Moody, D. Branch Bunyavanich, Supinda Bacharier, Leonard B. Kelly, Rachel S. Cheng, Tan-Yun Gold, Diane R. Savage, Jessica H. Weiss, Scott T. Sandel, Megan T. Lasky-Su, Jessica Litonjua, Augusto A. Mola, Alex R. Comstock, Laurie E. |
AuthorAffiliation | a Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass c Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass e Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass h Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass i Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY d Kaiser Permanente Southern California, San Diego, Calif g Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children’s Hospital, St Louis, Mo b Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass f Department of Pediatrics, Boston Medical Center, Boston, Mass |
AuthorAffiliation_xml | – name: h Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass – name: g Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children’s Hospital, St Louis, Mo – name: i Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY – name: f Department of Pediatrics, Boston Medical Center, Boston, Mass – name: b Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass – name: a Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass – name: e Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass – name: d Kaiser Permanente Southern California, San Diego, Calif – name: c Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass |
Author_xml | – sequence: 1 givenname: Kathleen surname: Lee-Sarwar fullname: Lee-Sarwar, Kathleen email: klee-sarwar@partners.org organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 2 givenname: Rachel S. surname: Kelly fullname: Kelly, Rachel S. organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 3 givenname: Jessica surname: Lasky-Su fullname: Lasky-Su, Jessica organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 4 givenname: D. Branch surname: Moody fullname: Moody, D. Branch organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 5 givenname: Alex R. surname: Mola fullname: Mola, Alex R. organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 6 givenname: Tan-Yun surname: Cheng fullname: Cheng, Tan-Yun organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 7 givenname: Laurie E. surname: Comstock fullname: Comstock, Laurie E. organization: Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 8 givenname: Robert S. surname: Zeiger fullname: Zeiger, Robert S. organization: Kaiser Permanente Southern California, San Diego, Calif – sequence: 9 givenname: George T. surname: O'Connor fullname: O'Connor, George T. organization: Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Mass – sequence: 10 givenname: Megan T. surname: Sandel fullname: Sandel, Megan T. organization: Department of Pediatrics, Boston Medical Center, Boston, Mass – sequence: 11 givenname: Leonard B. surname: Bacharier fullname: Bacharier, Leonard B. organization: Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo – sequence: 12 givenname: Avraham surname: Beigelman fullname: Beigelman, Avraham organization: Division of Pediatric Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo – sequence: 13 givenname: Nancy surname: Laranjo fullname: Laranjo, Nancy organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 14 givenname: Diane R. surname: Gold fullname: Gold, Diane R. organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 15 givenname: Supinda surname: Bunyavanich fullname: Bunyavanich, Supinda organization: Department of Pediatrics – Allergy/Immunology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY – sequence: 16 givenname: Jessica H. surname: Savage fullname: Savage, Jessica H. organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 17 givenname: Scott T. surname: Weiss fullname: Weiss, Scott T. organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 18 givenname: Patrick J. surname: Brennan fullname: Brennan, Patrick J. organization: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass – sequence: 19 givenname: Augusto A. surname: Litonjua fullname: Litonjua, Augusto A. email: augusto_litonjua@urmc.rochester.edu organization: Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29729303$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtv1DAUhS1URKeFP8ACRWLDJsGvvBBCQhW0lSqxgbXlODeTGzz2YGcGzb_HYVoEsygbW74-39XRORfkzHkHhLxktGCUVW-nYtIGC05ZU1BZpNETsmK0rfOq4eUZWVHasryqZXtOLmKcaHqLpn1Gznlb81ZQsSLq1s0QZ3TaZhs0wXeobd5DwD30WdyO6Nbe4hb7mOkAGbo9hAj2kOkYvUE9J9lPnMfMjGj70fs-G5ZDWwthfXhOng7aRnhxf1-Sb58_fb26ye--XN9efbzLjWzpnEx2uq0HKrnpKk55WfemalmrKQBIgLIqDYeGQsVYDaIRUjRdV0oQFWVDx8Ul-XDcu911G-gNuDloq7YBNzoclNeo_v1xOKq136tKCsF4mRa8uV8Q_I9dikRtMBqwVjvwu6g4FSWXdcNEkr4-kU5-F1KCi6oSnDP-W_Xqb0d_rDxknwTNUZBSjzHAoAzOeka_GESrGFVLzWpSS81qqVlRqdIoofwEfdj-KPT-CEHqYY8QVDQIzkCPAcyseo-P4-9OcGPRodH2Oxz-B_8C36nV5Q |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_972103 crossref_primary_10_1097_MOP_0000000000000806 crossref_primary_10_1053_j_gastro_2021_03_016 crossref_primary_10_1016_j_immuni_2020_07_025 crossref_primary_10_1111_all_16005 crossref_primary_10_1016_j_jfca_2024_106815 crossref_primary_10_1016_j_ajcnut_2024_11_011 crossref_primary_10_26599_FSHW_2024_9250044 crossref_primary_10_1111_all_16429 crossref_primary_10_1128_spectrum_00634_21 crossref_primary_10_1080_1744666X_2022_2101450 crossref_primary_10_26599_FSHW_2023_9250049 crossref_primary_10_1016_j_clim_2024_109928 crossref_primary_10_1128_Spectrum_00859_21 crossref_primary_10_1016_j_chom_2019_04_002 crossref_primary_10_1016_j_jaci_2020_01_012 crossref_primary_10_1016_j_anai_2018_12_012 crossref_primary_10_3389_falgy_2021_675557 crossref_primary_10_3389_fnut_2022_935711 crossref_primary_10_1016_j_anai_2019_09_017 crossref_primary_10_1111_nyas_14654 crossref_primary_10_1111_pai_14267 crossref_primary_10_1111_all_13563 crossref_primary_10_1111_all_15960 crossref_primary_10_1002_clt2_12339 crossref_primary_10_1016_j_jaci_2024_02_024 crossref_primary_10_1111_all_15602 crossref_primary_10_3390_nu14235155 crossref_primary_10_1007_s43393_024_00306_3 crossref_primary_10_1021_acs_jafc_4c05373 crossref_primary_10_1111_cea_14517 crossref_primary_10_3390_foods11213454 crossref_primary_10_1002_mnfr_202100536 crossref_primary_10_1016_j_jaci_2019_10_019 crossref_primary_10_1016_j_aninu_2020_05_007 crossref_primary_10_3390_app15062940 crossref_primary_10_1111_pai_13042 crossref_primary_10_1016_j_jaci_2019_10_014 crossref_primary_10_1111_pai_14133 crossref_primary_10_1016_j_jaip_2020_07_044 crossref_primary_10_1016_j_jaci_2021_10_034 |
Cites_doi | 10.1073/pnas.1415357111 10.1006/anae.1995.1009 10.1371/journal.pone.0061217 10.1186/s13059-014-0550-8 10.1186/2049-2618-1-17 10.1371/journal.pbio.1001610 10.1038/nature11209 10.1073/pnas.0915056107 10.1016/j.jaci.2016.08.045 10.1128/IAI.59.6.2075-2082.1991 10.1101/gr.112730.110 10.1038/nri.2016.111 10.1128/AEM.00003-14 10.1073/pnas.1705882114 10.1128/IAI.01348-10 10.18637/jss.v059.i05 10.1186/1471-2105-9-559 10.1111/all.13232 10.1038/ni.2143 10.1084/jem.180.3.1097 10.1016/j.jaci.2011.02.026 10.1001/jama.2015.18589 10.1038/nmeth.f.303 10.1038/nature06244 |
ContentType | Journal Article |
Copyright | 2018 American Academy of Allergy, Asthma & Immunology Copyright Elsevier Limited Jul 2018 |
Copyright_xml | – notice: 2018 American Academy of Allergy, Asthma & Immunology – notice: Copyright Elsevier Limited Jul 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 5PM |
DOI | 10.1016/j.jaci.2018.04.016 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | Entomology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 338.e9 |
ExternalDocumentID | PMC6433125 29729303 10_1016_j_jaci_2018_04_016 S0091674918306286 |
Genre | Letter Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Correspondence Letter to the Editor |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: K08 AI102945 – fundername: NHLBI NIH HHS grantid: T32 HL007427 – fundername: NIAID NIH HHS grantid: R01 AI118833 – fundername: NHLBI NIH HHS grantid: U01 HL091528 – fundername: NHLBI NIH HHS grantid: R01 HL108818 – fundername: NIAID NIH HHS grantid: T32 AI007306 – fundername: NHLBI NIH HHS grantid: R01 HL091528 – fundername: NIAMS NIH HHS grantid: R01 AR048632 – fundername: NIH HHS grantid: UH3 OD023268 |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM AACTN RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-c490t-67ba97f042cb620257dc6919a0eee4ee565c2e80e6117e383438bb54e3601fb23 |
IEDL.DBID | .~1 |
ISSN | 0091-6749 1097-6825 |
IngestDate | Thu Aug 21 14:11:44 EDT 2025 Mon Jul 21 09:44:03 EDT 2025 Sat Aug 23 13:12:18 EDT 2025 Mon Jul 21 05:58:29 EDT 2025 Thu Apr 24 23:10:39 EDT 2025 Tue Jul 01 00:47:36 EDT 2025 Sun Apr 06 06:53:20 EDT 2025 Tue Aug 26 16:36:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c490t-67ba97f042cb620257dc6919a0eee4ee565c2e80e6117e383438bb54e3601fb23 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-2 content type line 14 ObjectType-Letter to the Editor-1 ObjectType-Article-2 ObjectType-Correspondence-1 content type line 23 These authors contributed equally to this work. Current/present address: Jessica H. Savage is currently at Vertex Pharmaceuticals, Boston, Mass and Augusto A. Litonjua is at the Division of Pediatric Pulmonary Medicine, Golisano Children’s Hospital at University of Rochester Medical Center, Rochester, NY. |
PMID | 29729303 |
PQID | 2063221213 |
PQPubID | 105664 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6433125 proquest_miscellaneous_2035247813 proquest_journals_2063221213 pubmed_primary_29729303 crossref_citationtrail_10_1016_j_jaci_2018_04_016 crossref_primary_10_1016_j_jaci_2018_04_016 elsevier_sciencedirect_doi_10_1016_j_jaci_2018_04_016 elsevier_clinicalkey_doi_10_1016_j_jaci_2018_04_016 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-07-01 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationTitleAlternate | J Allergy Clin Immunol |
PublicationYear | 2018 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | McHardy, Goudarzi, Tong, Ruegger, Schwager, Weger (bib3) 2013; 1 Wieland Brown, Penaranda, Kashyap, Williams, Clardy, Kronenberg (bib7) 2013; 11 Jyonouchi, Abraham, Orange, Spergel, Gober, Dudek (bib6) 2011; 128 Turnbaugh, Turnbaugh, Ley, Ley, Hamady, Hamady (bib8) 2007; 449 Ling, Li, Liu, Cheng, Luo, Tong (bib2) 2014; 80 Yu, Freeland, Nadeau (bib1) 2016; 16 Kato, Muto, Tanaka-Bandoh, Watanabe, Ueno (bib5) 1995; 1 Litonjua, Carey, Laranjo, Harshfield, McElrath, O'Connor (bib4) 2016; 315 Litonjua (10.1016/j.jaci.2018.04.016_bib4) 2016; 315 Brennan (10.1016/j.jaci.2018.04.016_bibE15) 2011; 12 McHardy (10.1016/j.jaci.2018.04.016_bib3) 2013; 1 Zitomersky (10.1016/j.jaci.2018.04.016_bibE17) 2011; 79 Caporaso (10.1016/j.jaci.2018.04.016_bibE5) 2010; 7 Haas (10.1016/j.jaci.2018.04.016_bibE4) 2011; 21 (10.1016/j.jaci.2018.04.016_bibE3) 2012; 486 Kato (10.1016/j.jaci.2018.04.016_bib5) 1995; 1 Sordillo (10.1016/j.jaci.2018.04.016_bibE2) 2017; 139 Yu (10.1016/j.jaci.2018.04.016_bib1) 2016; 16 Love (10.1016/j.jaci.2018.04.016_bibE9) 2014; 15 Pantosti (10.1016/j.jaci.2018.04.016_bibE16) 1991; 59 Brennan (10.1016/j.jaci.2018.04.016_bibE12) 2017; 114 Tingley (10.1016/j.jaci.2018.04.016_bibE10) 2014; 59 Muindi (10.1016/j.jaci.2018.04.016_bibE14) 2010; 107 Wieland Brown (10.1016/j.jaci.2018.04.016_bib7) 2013; 11 Ling (10.1016/j.jaci.2018.04.016_bib2) 2014; 80 McMurdie (10.1016/j.jaci.2018.04.016_bibE6) 2013; 8 Turnbaugh (10.1016/j.jaci.2018.04.016_bib8) 2007; 449 Langfelder (10.1016/j.jaci.2018.04.016_bibE8) 2008; 9 Lantz (10.1016/j.jaci.2018.04.016_bibE13) 1994; 180 Evans (10.1016/j.jaci.2018.04.016_bibE7) 2014; 4 Jyonouchi (10.1016/j.jaci.2018.04.016_bib6) 2011; 128 Savage (10.1016/j.jaci.2018.04.016_bibE1) 2018; 73 Brennan (10.1016/j.jaci.2018.04.016_bibE11) 2014; 111 |
References_xml | – volume: 1 start-page: 17 year: 2013 ident: bib3 article-title: Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships publication-title: Microbiome – volume: 11 year: 2013 ident: bib7 article-title: Production of α-galactosylceramide by a prominent member of the human gut microbiota publication-title: PLoS Biol – volume: 128 start-page: 102 year: 2011 end-page: 109 ident: bib6 article-title: Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin publication-title: J Allergy Clin Immunol – volume: 80 start-page: 2546 year: 2014 end-page: 2554 ident: bib2 article-title: Altered fecal microbiota composition associated with food allergy in infants publication-title: Appl Environ Microbiol – volume: 16 start-page: 751 year: 2016 end-page: 765 ident: bib1 article-title: Food allergy: immune mechanisms, diagnosis and immunotherapy publication-title: Nat Rev Immunol – volume: 449 start-page: 804 year: 2007 end-page: 810 ident: bib8 article-title: The human microbiome project publication-title: Nature – volume: 315 start-page: 362 year: 2016 end-page: 370 ident: bib4 article-title: Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial publication-title: JAMA – volume: 1 start-page: 135 year: 1995 end-page: 139 ident: bib5 article-title: Sphingolipid composition in Bacteroides species publication-title: Anaerobe – volume: 111 start-page: 13433 year: 2014 ident: 10.1016/j.jaci.2018.04.016_bibE11 article-title: Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1415357111 – volume: 1 start-page: 135 year: 1995 ident: 10.1016/j.jaci.2018.04.016_bib5 article-title: Sphingolipid composition in Bacteroides species publication-title: Anaerobe doi: 10.1006/anae.1995.1009 – volume: 4 start-page: 1 year: 2014 ident: 10.1016/j.jaci.2018.04.016_bibE7 article-title: Metabolomics: open access high resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics publication-title: Metabolomics – volume: 8 year: 2013 ident: 10.1016/j.jaci.2018.04.016_bibE6 article-title: Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data publication-title: PLoS One doi: 10.1371/journal.pone.0061217 – volume: 15 start-page: 550 year: 2014 ident: 10.1016/j.jaci.2018.04.016_bibE9 article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 publication-title: Genome Biol doi: 10.1186/s13059-014-0550-8 – volume: 1 start-page: 17 year: 2013 ident: 10.1016/j.jaci.2018.04.016_bib3 article-title: Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships publication-title: Microbiome doi: 10.1186/2049-2618-1-17 – volume: 11 year: 2013 ident: 10.1016/j.jaci.2018.04.016_bib7 article-title: Production of α-galactosylceramide by a prominent member of the human gut microbiota publication-title: PLoS Biol doi: 10.1371/journal.pbio.1001610 – volume: 486 start-page: 215 year: 2012 ident: 10.1016/j.jaci.2018.04.016_bibE3 article-title: A framework for human microbiome research publication-title: Nature doi: 10.1038/nature11209 – volume: 107 start-page: 3052 year: 2010 ident: 10.1016/j.jaci.2018.04.016_bibE14 article-title: Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0915056107 – volume: 139 start-page: 482 year: 2017 ident: 10.1016/j.jaci.2018.04.016_bibE2 article-title: Factors influencing the infant gut microbiome at age 3-6 months: findings from the ethnically diverse Vitamin D Antenatal Asthma Reduction Trial (VDAART) publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2016.08.045 – volume: 59 start-page: 2075 year: 1991 ident: 10.1016/j.jaci.2018.04.016_bibE16 article-title: Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis publication-title: Infect Immun doi: 10.1128/IAI.59.6.2075-2082.1991 – volume: 21 start-page: 494 year: 2011 ident: 10.1016/j.jaci.2018.04.016_bibE4 article-title: Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons publication-title: Genome Res doi: 10.1101/gr.112730.110 – volume: 16 start-page: 751 year: 2016 ident: 10.1016/j.jaci.2018.04.016_bib1 article-title: Food allergy: immune mechanisms, diagnosis and immunotherapy publication-title: Nat Rev Immunol doi: 10.1038/nri.2016.111 – volume: 80 start-page: 2546 year: 2014 ident: 10.1016/j.jaci.2018.04.016_bib2 article-title: Altered fecal microbiota composition associated with food allergy in infants publication-title: Appl Environ Microbiol doi: 10.1128/AEM.00003-14 – volume: 114 start-page: 8348 year: 2017 ident: 10.1016/j.jaci.2018.04.016_bibE12 article-title: Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1705882114 – volume: 79 start-page: 2012 year: 2011 ident: 10.1016/j.jaci.2018.04.016_bibE17 article-title: Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut publication-title: Infect Immun doi: 10.1128/IAI.01348-10 – volume: 59 start-page: 1 year: 2014 ident: 10.1016/j.jaci.2018.04.016_bibE10 article-title: Mediation: R Package for Causal Mediation Analysis publication-title: J Stat Softw doi: 10.18637/jss.v059.i05 – volume: 9 start-page: 559 year: 2008 ident: 10.1016/j.jaci.2018.04.016_bibE8 article-title: an R package for weighted correlation network analysis publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-9-559 – volume: 73 start-page: 145 year: 2018 ident: 10.1016/j.jaci.2018.04.016_bibE1 article-title: A prospective microbiome-wide association study of food sensitization and food allergy in early childhood publication-title: Allergy doi: 10.1111/all.13232 – volume: 12 start-page: 1202 year: 2011 ident: 10.1016/j.jaci.2018.04.016_bibE15 article-title: Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals publication-title: Nat Immunol doi: 10.1038/ni.2143 – volume: 180 start-page: 1097 year: 1994 ident: 10.1016/j.jaci.2018.04.016_bibE13 article-title: An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8− T cells in mice and humans publication-title: J Exp Med doi: 10.1084/jem.180.3.1097 – volume: 128 start-page: 102 year: 2011 ident: 10.1016/j.jaci.2018.04.016_bib6 article-title: Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2011.02.026 – volume: 315 start-page: 362 year: 2016 ident: 10.1016/j.jaci.2018.04.016_bib4 article-title: Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2015.18589 – volume: 7 start-page: 335 year: 2010 ident: 10.1016/j.jaci.2018.04.016_bibE5 article-title: QIIME allows analysis of high-throughput community sequencing data publication-title: Nat Methods doi: 10.1038/nmeth.f.303 – volume: 449 start-page: 804 year: 2007 ident: 10.1016/j.jaci.2018.04.016_bib8 article-title: The human microbiome project publication-title: Nature doi: 10.1038/nature06244 |
SSID | ssj0009389 |
Score | 2.4635942 |
Snippet | [...]we adjusted for age in all analyses, performed sensitivity analyses of key results adjusting for other potential confounders, and tested for associations... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 335 |
SubjectTerms | Age Antigens Asthma Bacteroides Bacteroides fragilis - metabolism Cesarean section Child, Preschool Children Eigenvalues Feces Female Food allergies Food Hypersensitivity - immunology Food Hypersensitivity - metabolism Food Hypersensitivity - microbiology Gastrointestinal Microbiome - immunology Genotype & phenotype Humans Hypotheses Infant Intestine Lipids Male Mediation Metabolites Natural Killer T-Cells - immunology Pruritus Sphingolipids Sphingolipids - immunology Sphingolipids - metabolism |
Title | Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergy |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674918306286 https://dx.doi.org/10.1016/j.jaci.2018.04.016 https://www.ncbi.nlm.nih.gov/pubmed/29729303 https://www.proquest.com/docview/2063221213 https://www.proquest.com/docview/2035247813 https://pubmed.ncbi.nlm.nih.gov/PMC6433125 |
Volume | 142 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KBfFF_PZsLRF8k9hLstmPx1Isp9I-WejbsruZaMo1d9xdhb74t3cm2URPpYIvgWRnQzKZmf3t5jezAG8zraXXQaayUpgKo4tUCwxpXilFA1wthefc4dMzOTsXny7Kix04HnJhmFYZY38f07toHa8cRm0eLpuGc3wNU-gNGSUnAnLZbSEUW_n7Hz9pHqbQPQQ2WcrSMXGm53hdutAwvUt35U55z_O_D05_gs_fOZS_DEonj-BhRJPJUf_Aj2EH2ydw_zT-L38Klhf8yIlZ6Krpai65eVqR1X3HKlkveflpMW-WTbVO3AqTpmWWBs5vEhc_G4nxUm0ShhLISc0H3oFl9fXmGZyffPhyPEvjlgppEGa6IQ14Z1RNnhq8zAnvqCpIkxk3RUSBSPAu5KinKLNMIc1eRaG9LwUWNHGrfV48h9120eJLSPLc1YS1QikrR46vvaA7-iLzLmijTDaBbNClDbHeOG97MbcDsezSsv4t699OhaVLE3g39ln21TbulC6GT2SHPFKKfJYGgzt7lWOvLUv7Z7_9wQps9PM1tUuKiFwWbwJvxmbyUP7t4lpcXLMMgVzO6CWZF73RjC-XG5rcEIqYgNoyp1GAq39vt7TNt64KuORct7x89Z-vswcP-KxnHu_D7mZ1ja8JX238QedAB3Dv6OPn2dktE3klfQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NTgJeEL_pGBAk3lC0JnEc-3GamDq29mmT9mbZzgUydWnVdkj773fXOIECGhIvfYjvouZyd_7s3H0G-JQoJZ3yMpZlgbHQKouVQB-nZVHQBFdJ4bh3eDKV4wvx9TK_3IGjrheGyypD7m9z-iZbhysHwZoHi7rmHl_NJfSanJIbAeUD2GV2qnwAu4cnp-PpT-7dTLUoWCcxK4TembbM68r6miu81IbxlI89__v89Cf-_L2M8pd56fgpPAmAMjps__Mz2MHmOTychE_mL8Dwnh_FMQtd1xvaJTuLS3K8H1hGqwXvQM1n9aIuV5FdYlQ3XKiBs9vIhjdHYrxbG_mOBTmq-IcPYVl-u30JF8dfzo_GcThVIfZCj9ZkAWd1UVGweidTgjxF6aVOtB0hokAkhOdTVCOUSVIgLWBFppzLBWa0dqtcmr2CQTNv8A1EaWorgls-l6Wl2FdO0B1dljjrlS50MoSks6XxgXKcT76Yma627Mqw_Q3b34yEoUtD-NzrLFrCjXuls-4Vma6VlJKfofngXq2819pytn_q7XdeYEKor2hcUlJkZrwhfOyHKUj5y4ttcH7DMoRzuamXZF63TtM_XKppfUNAYgjFljv1AkwAvj3S1N83ROCS293SfO8_H-cDPBqfT87M2cn09C085pG2EHkfBuvlDb4juLV270M43QEI7ygu |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intestinal+microbial-derived+sphingolipids+are+inversely+associated+with+childhood+food+allergy&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Lee-Sarwar%2C+Kathleen&rft.au=Kelly%2C+Rachel+S&rft.au=Lasky-Su%2C+Jessica&rft.au=D+Branch+Moody&rft.date=2018-07-01&rft.pub=Elsevier+Limited&rft.issn=0091-6749&rft.eissn=1097-6825&rft.volume=142&rft.issue=1&rft.spage=335&rft_id=info:doi/10.1016%2Fj.jaci.2018.04.016&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon |